| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |